APA

Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W. & Ringdén O. (20080522). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. : Lancet (London, England).

Chicago

Le Blanc Katarina, Frassoni Francesco, Ball Lynne, Locatelli Franco, Roelofs Helene, Lewis Ian, Lanino Edoardo, Sundberg Berit, Bernardo Maria Ester, Remberger Mats, Dini Giorgio, Egeler R Maarten, Bacigalupo Andrea, Fibbe Willem and Ringdén Olle. 20080522. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. : Lancet (London, England).

Harvard

Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W. and Ringdén O. (20080522). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. : Lancet (London, England).

MLA

Le Blanc Katarina, Frassoni Francesco, Ball Lynne, Locatelli Franco, Roelofs Helene, Lewis Ian, Lanino Edoardo, Sundberg Berit, Bernardo Maria Ester, Remberger Mats, Dini Giorgio, Egeler R Maarten, Bacigalupo Andrea, Fibbe Willem and Ringdén Olle. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. : Lancet (London, England). 20080522.